Evidence map›Paper›PMID 40681519›Full record

ReviewNPJ biofilms and microbiomes2025

Parabacteroides as a promising target for disease intervention: current stage and pending issues.

Jing Liu, Hui Qiu, Jiamin Zhao, Nan Shao, Chao Chen, Zhixu He, Xu Zhao, Juanjuan Zhao, Ya Zhou, Lin Xu

Abstract readReview
In one paragraph

Review in NPJ biofilms and microbiomes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. International journal of molecular sciences · 2026
    Article
  16. Article
  17. Frontiers in veterinary science · 2026
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jing LiuKey Laboratory of Cancer Prevention & Treatment of Guizhou Province, Zunyi Medical University, Zunyi Guizhou, China.
Hui QiuKey Laboratory of Cancer Prevention & Treatment of Guizhou Province, Zunyi Medical University, Zunyi Guizhou, China.
Jiamin ZhaoKey Laboratory of Cancer Prevention & Treatment of Guizhou Province, Zunyi Medical University, Zunyi Guizhou, China.
Nan ShaoKey Laboratory of Cancer Prevention & Treatment of Guizhou Province, Zunyi Medical University, Zunyi Guizhou, China.
Chao ChenKey Laboratory of Cancer Prevention & Treatment of Guizhou Province, Zunyi Medical University, Zunyi Guizhou, China.
Zhixu HeKey Laboratory of Cancer Prevention & Treatment of Guizhou Province, Zunyi Medical University, Zunyi Guizhou, China.
Xu ZhaoKey Laboratory of Cancer Prevention & Treatment of Guizhou Province, Zunyi Medical University, Zunyi Guizhou, China.
Juanjuan ZhaoKey Laboratory of Cancer Prevention & Treatment of Guizhou Province, Zunyi Medical University, Zunyi Guizhou, China. zhaojj.2008@163.com.
Ya ZhouKey Laboratory of Cancer Prevention & Treatment of Guizhou Province, Zunyi Medical University, Zunyi Guizhou, China. zhouyazmc@163.com.
Lin XuKey Laboratory of Cancer Prevention & Treatment of Guizhou Province, Zunyi Medical University, Zunyi Guizhou, China. xulinzhouya@163.com.

Funding

the National Natural Science Foundation of China No. 82160503
6 · The paper itself

Abstract

Parabacteroides, a promising candidate for the next generation of probiotics, plays a significant role in various diseases. In this review, we provide a comprehensive examination of the biological properties of Parabacteroides, summarize its effects on host health and potential associations with diseases, and discuss unresolved scientific questions regarding this genus. Our aim is to offer novel insights for the development of targeted gut microbiota interventions and their translational applications.

Indexed as

BacteroidetesGastrointestinal MicrobiomeProbioticsAnimalsHumans

Identifiers

PMID40681519
PMCPMC12274597

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.